Osteoarthritis I: Epidemiological risk factors and historical considerations

Author： Buchanan W. Watson   Kean Walter F.  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.10, Iss.1-2, 2002-02, pp. : 5-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins increase risk of incident hip osteoarthritis

By  

Reactions Weekly, Vol. 1, Iss. 1040, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Rofecoxib in the Treatment of Osteoarthritis

By Schmidt H.   Woodcock B.G.   Geisslinger G.  

Drug Safety, Vol. 27, Iss. 3, 2004-01 ,pp. : 185-196

Adis International

Access to resources Recommend Favorite

The discovery of angiogenic factors: - A historical review

By Ribatti D.   Vacca A.   Presta M.  

General Pharmacology, Vol. 35, Iss. 5, 2000-11 ,pp. : 227-231

Elsevier

Access to resources Recommend Favorite

Risk Factors for Cardiovascular and Ischaemic Heart Disease in a Mediterranean Country: Preliminary Report of the Zaragoza Study (ZACARIS-I)

By Ibáñez A.M.  

Clinical Drug Investigation, Vol. 22, Iss. 4, 2002-01 ,pp. : 241-251

Adis International

Access to resources Recommend Favorite

Epidemiological Investigation of Metabolic Syndrome and Analysis of Relevant Factors in North-eastern China

By Wang W   Kong J   Sun J   Wang CY   Chen HY   Jiang YF   Feng XW   He SM   Niu JQ  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 150-159

Field House Publishing

Access to resources Recommend Favorite